FindTrial
Sign In

UTAA91 injection

BIOLOGICAL5 trials

Sponsors

PersonGen BioTherapeutics (Suzhou) Co., Ltd., Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Dry SyndromeIdiopathic Inflammatory MyopathiesRheumatoid ArthritisRheumatoid Arthritis (RA)Systemic Lupus ErythematosusSystemic SclerosisSystemic Sclerosis (SSc)

Early Phase 1

Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Not yet recruitingNCT06970951
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Dry Syndrome, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis +2
Start: 2025-05-18End: 2027-04-30Target: 15Updated: 2025-05-14
Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection
Not yet recruitingNCT06982547
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Rheumatoid Arthritis (RA)
Start: 2025-06-30End: 2040-06-30Target: 24Updated: 2025-05-21
Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.
Not yet recruitingNCT06982534
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Systemic Sclerosis (SSc)
Start: 2025-06-30End: 2040-01-31Target: 24Updated: 2025-05-21
The Clinical Study on the Treatment of SSc With UTAA91 Injection.
RecruitingNCT07000682
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySystemic Sclerosis (SSc)
Start: 2025-05-30End: 2040-01-31Target: 24Updated: 2025-07-18
The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
RecruitingNCT07001956
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRheumatoid Arthritis (RA)
Start: 2025-05-30End: 2040-06-30Target: 24Updated: 2025-07-18